These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1179 related items for PubMed ID: 26148052

  • 41. Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004-2017): Assessment of trends, risks and need for implementing routine testing.
    Miletić M, Bingulac-Popović J, Stojić Vidović M, Hećimović A, Berendika M, Babić I, Đogić V, Samardžija M, Barišić K, Jukić I, Mihaljević I.
    Transfus Clin Biol; 2019 Nov; 26(4):257-262. PubMed ID: 31153786
    [Abstract] [Full Text] [Related]

  • 42. Incidences of new hepatitis B infection and anti-hepatitis B core-negative occult hepatitis B infection among Japanese blood donors in relation to anti-hepatitis B surface antigen levels.
    Satake M, Sugiyama M, Mizokami M, Tanaka J.
    J Med Virol; 2024 Jul; 96(7):e29823. PubMed ID: 39039862
    [Abstract] [Full Text] [Related]

  • 43. Investigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic.
    Martinez MC, Kok CC, Baleriola C, Robertson P, Rawlinson WD.
    PLoS One; 2015 Jul; 10(3):e0117275. PubMed ID: 25763579
    [Abstract] [Full Text] [Related]

  • 44. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects.
    Azarkar Z, Ziaee M, Ebrahimzadeh A, Sharifzadeh G, Javanmard D.
    J Med Virol; 2019 Apr; 91(4):615-622. PubMed ID: 30345529
    [Abstract] [Full Text] [Related]

  • 45. Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique.
    Mabunda N, Zicai AF, Ismael N, Vubil A, Mello F, Blackard JT, Lago B, Duarte V, Moraes M, Lewis L, Jani I.
    Mem Inst Oswaldo Cruz; 2020 Apr; 115():e200006. PubMed ID: 32997000
    [Abstract] [Full Text] [Related]

  • 46. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S, Chetsanga C, Nyström L, Moyo S, Nzara M, Chieza L.
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [Abstract] [Full Text] [Related]

  • 47. Prevalence of "anti-HBc alone" among Syrian blood donors.
    Muselmani W, Habbal W, Monem F.
    J Infect Dev Ctries; 2014 Aug 13; 8(8):1013-5. PubMed ID: 25116667
    [Abstract] [Full Text] [Related]

  • 48. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO.
    Virol J; 2016 May 05; 13():76. PubMed ID: 27150469
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N, Kırdar S, Uzun N, Eyigör M, Sayan M.
    Mikrobiyol Bul; 2016 Oct 05; 50(4):535-543. PubMed ID: 28124958
    [Abstract] [Full Text] [Related]

  • 51. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening.
    Seed CR, Kiely P.
    Vox Sang; 2013 Nov 05; 105(4):290-8. PubMed ID: 23802710
    [Abstract] [Full Text] [Related]

  • 52. Evaluation of occult hepatitis B infection in tissue donors: a multicenter analysis in Spain.
    Sánchez Ibáñez J, Vilarrodona Serrat A, Seoane Pillado T, Rodriguez Aierbe C, Villalba Montoro R, Calvo Benito J, Pevida Lopez M, Fernández Paneque S, Vuelta Lopez E, Martínez Lorenzo MJ, González Romero M, Cañizares Castellanos A, Sauleda Oliveras S.
    Cell Tissue Bank; 2019 Dec 05; 20(4):513-526. PubMed ID: 31451994
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT.
    Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group.
    Hepatology; 2006 Dec 05; 44(6):1666-74. PubMed ID: 17133474
    [Abstract] [Full Text] [Related]

  • 56. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec 05; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 57. Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria.
    Nna E, Mbamalu C, Ekejindu I.
    Pathog Glob Health; 2014 Jul 05; 108(5):223-8. PubMed ID: 24995918
    [Abstract] [Full Text] [Related]

  • 58. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study.
    Ogunfemi MK, Olawumi HO, Olokoba AB, Kagu MB, Biliaminu SA, Durowade KA, Durotoye IA, Shittu AO.
    Malawi Med J; 2017 Mar 05; 29(1):32-36. PubMed ID: 28567194
    [Abstract] [Full Text] [Related]

  • 59. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    Gachara G, Magoro T, Mavhandu L, Lum E, Kimbi HK, Ndip RN, Bessong PO.
    AIDS Res Ther; 2017 Mar 08; 14(1):11. PubMed ID: 28270215
    [Abstract] [Full Text] [Related]

  • 60. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.
    Transfusion; 2010 Jan 08; 50(1):221-30. PubMed ID: 19682332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.